Clinical Edge Journal Scan

Clinical Edge Journal Scan

Commentary: Bendamustine, PET/CT Biomarkers, and BTKi in B-Cell Lymphoma, December 2023

Publish date: December 11, 2023

• Read More

Clinical Edge Journal Scan

Patients with MCL more prone to develop secondary malignancies

Publish date: November 15, 2023

• Read More

Clinical Edge Journal Scan

Combination of time-limited ibrutinib and chimeric antigen receptor T-cells shows promise in r/r MCL

Publish date: November 15, 2023

• Read More

Clinical Edge Journal Scan

Axi-cel vs tisagenlecleucel improves efficacy but may cause higher neurologic toxicity in LBCL

Publish date: November 15, 2023

• Read More

Clinical Edge Journal Scan

PET/CT-biomarkers hold prognostic value in DLBCL

Publish date: November 15, 2023

• Read More

Clinical Edge Journal Scan

No benefit of ASCT over radioimmunotherapy in R/R FL in the rituximab age

Publish date: November 15, 2023

• Read More

Clinical Edge Journal Scan

TP53 mutations predict inferior outcomes in newly diagnosed aggressive BCL

Publish date: November 15, 2023

• Read More

Clinical Edge Journal Scan

Allogeneic HSCT offers a salvage treatment option for chemo-susceptible relapsed or refractory DLBCL

Publish date: November 15, 2023

• Read More

Clinical Edge Journal Scan

Ibrutinib-venetoclax tops chlorambucil-obinutuzumab in treatment-naïve CLL over a 4-year follow-up

Publish date: November 15, 2023

• Read More

Clinical Edge Journal Scan

Brexu-cel vs SOC improved survival in relapsed or refractory MCL

Publish date: November 15, 2023

• Read More

Pages

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• last »